동물 창상관리 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the animal wound care market size is expected to grow from USD 1.44 billion in 2025 to USD 1.55 billion in 2026 and is forecast to reach USD 2.25 billion by 2031 at 7.74% CAGR over 2026-2031.

This report is Segmented by Products (Surgical [Dressings, and More], Advanced [Foam Dressings, and More], Traditional, and Other Products), Animal Type (Companion [Dogs, and More], and Livestock), End Users (Veterinary Hospitals & Clinics, Home-Care Settings, and More), and Geography (North America, Europe, Asia Pacific, and More). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

Global Animal Wound Care Market Trends and Insights

Government & Welfare Initiatives

National welfare reforms are translating into mandatory protocols that elevate demand for evidence-based dressings. The 2024 USDA Animal Welfare Act amendments require analgesic hydrogel use during research procedures, pushing institutes to upgrade inventory . The European Union now restricts off-label use of human products on food-producing animals, channeling purchases toward veterinary-specific lines that meet residue standards. Australia's 2025 farm-animal welfare plan ties export eligibility to documented wound treatment records, nudging producers toward antimicrobial-impregnated foam. These measures create a compliance-driven floor for the animal wound care market while penalizing suppliers that lack comparative-efficacy dossiers. Over the medium term, enforcement intensity in developed regions will ripple into export-oriented emerging markets, widening the addressable user base for premium therapies.

Pet Adoption & Healthcare Spending

Companion-animal ownership that surged during the pandemic remains elevated, and owners are spending more per visit on wound management. U.S. households averaged USD 1,201 in annual veterinary outlays per dog in 2025, compared with USD 1,060 in 2022, with post-surgical care a key line item . Single-person households in Japan are adopting cats at twice the rate of multi-person homes and choose collagen or antimicrobial foams for even minor lacerations. In India, pet-insurance penetration doubled to 1.6% in 2025, reducing out-of-pocket resistance to advanced therapies. Higher discretionary spending offsets volume saturation in mature markets and fuels the adoption of premium dressings in emerging urban centers.

High Veterinary-Care Costs

Consultation fees climbed 18% between 2022 and 2025 in the United States, reaching USD 61 per routine visit and over USD 400 for emergency debridement . Australia, 34% of pet owners deferred recommended wound care in 2025 because of affordability concerns, with rates rising to 48% in low-income households. Budget pressure steers owners toward over-the-counter gauze that lacks antimicrobial or moisture-retention features, limiting penetration of premium products. Livestock producers weigh dressing costs against slim profit margins, often opting for minimal intervention unless compliance or export mandates intervene. In regions where pet insurance remains scarce, cost sensitivity threatens uptake of collagen dressings and negative-pressure devices despite their clinical advantages.

Other drivers and restraints analyzed in the detailed report include:

1. Advanced Wound-Dressing Adoption
2. Regenerative Therapies Adoption
3. Regulatory Complexity (EU)

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Surgical items accounted for 40.1% of revenue in 2025, reflecting high volumes of spay-neuter procedures and fracture repairs conducted across clinics worldwide. Cyanoacrylate adhesives are popular for avian and exotic cases because delicate skin tears under traditional sutures; Jorgensen Laboratories recorded a 29% sales uplift for Vetbond in 2025. Advanced dressings are projected to outpace the broader animal wound care market at 8.32% CAGR through 2031, buoyed by clinical evidence of shorter healing times and fewer dressing changes. Antimicrobial foams, hydrocolloids, and silver alginates also align with antibiotic-stewardship goals, positioning them as frontline choices against biofilm. Traditional cotton gauze continues to serve budget-constrained settings but is yielding share as veterinary curricula emphasize moisture management and infection control.

Advanced dressings' momentum underscores a shift in purchasing criteria from unit cost toward total cost of care. Clinics report fewer clinic visits and reduced anesthesia demand when moisture-retentive dressings are employed. Collagen dressings derived from bovine or porcine tissue are finding niches in equine limb wounds where granulation tissue forms slowly. The animal wound care market size for advanced dressings is expected to grow briskly as draft FDA guidance tightens antimicrobial classification, narrowing competitive sets and improving clinician confidence. Smaller manufacturers lacking regulatory resources may exit, further consolidating sales toward global suppliers with validated portfolios.

Complete Report Scope:

• By Product
  • Surgical
    • Dressings
    • Sutures & Staples
    • Tissue Adhesives
    • Others
  • Advanced
    • Foam Dressings
    • Hydrocolloid Dressings
    • Hydrogel Dressings
    • Alginate Dressings
    • Collagen Dressings
    • Antimicrobial Dressings
  • Traditional
    • Gauze
    • Adhesive Bandages
    • Cotton Swabs & Wraps
  • Other Products
    • Cell & Gene Therapies
    • Platelet Concentrates
    • NPWT Devices
• By Animal Type
  • Companion Animals
    • Dogs
    • Cats
    • Other Companion
  • Livestock Animals
    • Cattle
    • Swine
    • Poultry
    • Sheep & Goats
• By End User
  • Veterinary Hospitals & Clinics
  • Home-care Settings
  • Research & Academic Institutes
  • Animal Shelters & NGOs
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained a 39.76% share in 2025, supported by high pet ownership, robust insurance coverage, and rapid regulatory approvals. The FDA cleared 14 new wound-care devices between 2024 and 2025, enabling early adopter clinics to refresh formularies quickly. Canada benefits from regulatory alignment with the United States, although provincial variations introduce minor fragmentation. Mexico is emerging as a growth pole; a new Virbac distribution hub established in 2025 improves access across Central America and the southern United States.

Asia-Pacific is the fastest-growing region and is projected to post a 7.11% CAGR through 2031. Japan's per-household veterinary spend reached JPY 89,000 (USD 610) in 2025, with wound-care products comprising 9% of the total. China's dog and cat population surpassed 120 million in 2025, and Elanco's Shanghai training center is equipping clinicians with advanced dressing protocols. India shows double-digit growth in pet populations, and veterinary colleges have begun teaching modern wound-management modules. Australia and New Zealand feature mature, high-spend markets where insurers already reimburse advanced therapies, making them useful test beds for product launches.

Europe's stricter regulatory framework dampens short-term growth. Germany, the United Kingdom, and France remain sizable markets, but EMA compliance costs delay new product introductions. Spain and Italy are benefiting from rising ownership among younger demographics, while Poland and Hungary attract manufacturing investment. South America is anchored by Brazil, where livestock producers adopt antimicrobial foams to satisfy welfare-driven export requirements; Argentina's market rebounded in 2025 as currency stabilization improved import capacity. The Middle East and Africa remain underpenetrated, with meaningful demand concentrated in Gulf Cooperation Council countries and South Africa.

1. Advancis Veterinary Ltd.
2. Animalcare Group plc
3. B. Braun
4. Boehringer Ingelheim AH
5. Dechra Pharmaceuticals
6. Elanco
7. Innovacyn
8. Jorgensen Laboratories
9. KeriCure
10. Medtronic
11. Milliken & Company
12. MWI Animal Health
13. Neogen
14. Primavet
15. Sentrx Animal Care Inc.
16. Solventum
17. Vernacare
18. Vetoquinol
19. Virbac
20. Zoetis

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Government & Welfare Initiatives
  • 4.2.2 Pet Adoption & Healthcare Spending
  • 4.2.3 Advanced Wound-Dressing Adoption
  • 4.2.4 Intensive Livestock-Farming Injuries
  • 4.2.5 Tele-Veterinary Wound Management
  • 4.2.6 Regenerative Therapies Adoption
• 4.3 Market Restraints
  • 4.3.1 Lack Of Comparative Studies
  • 4.3.2 High Veterinary-Care Costs
  • 4.3.3 Regulatory Complexity (EMS)
  • 4.3.4 Limited Awareness
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Surgical
    • 5.1.1.1 Dressings
    • 5.1.1.2 Sutures & Staples
    • 5.1.1.3 Tissue Adhesives
    • 5.1.1.4 Others
  • 5.1.2 Advanced
    • 5.1.2.1 Foam Dressings
    • 5.1.2.2 Hydrocolloid Dressings
    • 5.1.2.3 Hydrogel Dressings
    • 5.1.2.4 Alginate Dressings
    • 5.1.2.5 Collagen Dressings
    • 5.1.2.6 Antimicrobial Dressings
  • 5.1.3 Traditional
    • 5.1.3.1 Gauze
    • 5.1.3.2 Adhesive Bandages
    • 5.1.3.3 Cotton Swabs & Wraps
  • 5.1.4 Other Products
    • 5.1.4.1 Cell & Gene Therapies
    • 5.1.4.2 Platelet Concentrates
    • 5.1.4.3 NPWT Devices
• 5.2 By Animal Type
  • 5.2.1 Companion Animals
    • 5.2.1.1 Dogs
    • 5.2.1.2 Cats
    • 5.2.1.3 Other Companion
  • 5.2.2 Livestock Animals
    • 5.2.2.1 Cattle
    • 5.2.2.2 Swine
    • 5.2.2.3 Poultry
    • 5.2.2.4 Sheep & Goats
• 5.3 By End User
  • 5.3.1 Veterinary Hospitals & Clinics
  • 5.3.2 Home-care Settings
  • 5.3.3 Research & Academic Institutes
  • 5.3.4 Animal Shelters & NGOs
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products, and Recent Developments)
  • 6.3.1 Advancis Veterinary Ltd.
  • 6.3.2 Animalcare Group plc
  • 6.3.3 B. Braun Vet Care GmbH
  • 6.3.4 Boehringer Ingelheim AH
  • 6.3.5 Dechra Pharmaceuticals PLC
  • 6.3.6 Elanco Animal Health
  • 6.3.7 Innovacyn Inc.
  • 6.3.8 Jorgensen Laboratories
  • 6.3.9 KeriCure Inc.
  • 6.3.10 Medtronic plc
  • 6.3.11 Milliken & Company
  • 6.3.12 MWI Animal Health
  • 6.3.13 Neogen Corporation
  • 6.3.14 Primavet Inc.
  • 6.3.15 Sentrx Animal Care Inc.
  • 6.3.16 Solventum
  • 6.3.17 Vernacare
  • 6.3.18 Vetoquinol SA
  • 6.3.19 Virbac
  • 6.3.20 Zoetis Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment